Krauth, Christian
Rossol, Siegbert
Ortsäter, Gustaf
Kautz, Achim
Krüger, Kathrin
Herder, Babette
Stahmeyer, Jona Theodor
Funding for this research was provided by:
Gilead Sciences
Article History
Received: 16 November 2018
Accepted: 30 September 2019
First Online: 2 December 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: This research was conducted with funding from Gilead Sciences. Achim Kautz and Babette Herder have no other conflict of interest to declare. Gustaf Ortsäter is employee of Quantify Research, a private research company. Christian Krauth received research funding by Gilead Sciences, Janssen-Cilag, AbbVie; Siegbert Rossol received research funding by Gilead Sciences and is advisory board member for MSD; Kathrin Krüger received research funding by Gilead Sciences; Jona T. Stahmeyer received research funding by Gilead Sciences, AbbVie and travel support/lecture fees by Roche. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the BMC Infectious Diseases policies on sharing data and materials.